REmission from Stage D Heart Failure (RESTAGE-HF)
Brief Description Of Study
This is a non-randomized, prospective, multi-center study. Forty subjects satisfying the inclusion and exclusion criteria listed below will be recruited at participating centers. Subjects will be recruited to the trial in a preliminary manner prior to LVAD implantation or within 4 weeks of LVAD implantation. Subjects will be followed for up to 3 years after explantation of the device, or until heart transplantation. All participating centers will maintain a screening log of patients with non-ischemic cardiomyopathy undergoing LVAD implantation.